These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 36699015)

  • 1. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
    Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
    Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid based personalized medicine: from bench to bedside.
    Li Y; Tang P; Cai S; Peng J; Hua G
    Cell Regen; 2020 Nov; 9(1):21. PubMed ID: 33135109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Organoids as Disease Models: Strengths, Weaknesses and Perspectives.
    Romero-Guevara R; Ioannides A; Xinaris C
    Front Physiol; 2020; 11():563981. PubMed ID: 33250772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primate Organoids and Gene-Editing Technologies toward Next-Generation Biomedical Research.
    Chen C; Ji W; Niu Y
    Trends Biotechnol; 2021 Dec; 39(12):1332-1342. PubMed ID: 33941418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancement of Organoid Technology in Regenerative Medicine.
    Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
    Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome engineering of stem cell organoids for disease modeling.
    Sun Y; Ding Q
    Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids.
    Na DH; Cui S; Fang X; Lee H; Eum SH; Shin YJ; Lim SW; Yang CW; Chung BH
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoids: The current status and biomedical applications.
    Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
    MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
    Dutta D; Heo I; Clevers H
    Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
    Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
    Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity.
    Liu S; Fang C; Zhong C; Li J; Xiao Q
    Cell Biol Toxicol; 2023 Dec; 39(6):2527-2549. PubMed ID: 37889357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell and Spatial Analysis of Emergent Organoid Platforms.
    Kumar A; Cai S; Allam M; Henderson S; Ozbeyler M; Saiontz L; Coskun AF
    Methods Mol Biol; 2023; 2660():311-344. PubMed ID: 37191807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.